The FDA’s approval of an mRNA flu shot presents a new, long-awaited option—and raises big questions about the future of flu ...
Every fall, millions of Americans heed the call to get their annual flu shot. Getting vaccinated reduces the risk of severe illness, hospitalization, and death from influenza. This fall, adults 50 and ...
Individualized vaccines are built from resected tumor, using analytics to prioritize neoantigens most likely to be immunogenic, then encoding these targets into an mRNA construct tailored to each ...
People looking to get their annual flu shot this fall may find a new option alongside the usual vaccines: an mRNA flu shot. Not everyone is eligible, however.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results